Cingulate CEO: $7.5M fundraising round will help drive pharma growth in KC
July 11, 2018 at 15:46 PM EDT
Cingulate Therapeutics of Kansas City, Kan., landed its first big fundraising round, at $7.5 million, and is preparing for growth with a new office. CEO Scott Schaffer says his company's growth will help turn the KC area into a pharmaceutical hub.
